CN116075516B - 可用于治疗呼吸道合胞病毒感染的苯二氮杂䓬衍生物 - Google Patents

可用于治疗呼吸道合胞病毒感染的苯二氮杂䓬衍生物

Info

Publication number
CN116075516B
CN116075516B CN202180053511.8A CN202180053511A CN116075516B CN 116075516 B CN116075516 B CN 116075516B CN 202180053511 A CN202180053511 A CN 202180053511A CN 116075516 B CN116075516 B CN 116075516B
Authority
CN
China
Prior art keywords
dihydro
phenyl
oxazine
oxo
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202180053511.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN116075516A (zh
Inventor
M·巴雷特
G·S·科克里尔
J·古德
C·A·艾弗里
E·J·科克伦
S·P·琼斯
S·T·奥尼恩斯
A·J·华纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN116075516A publication Critical patent/CN116075516A/zh
Application granted granted Critical
Publication of CN116075516B publication Critical patent/CN116075516B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN202180053511.8A 2020-07-07 2021-07-07 可用于治疗呼吸道合胞病毒感染的苯二氮杂䓬衍生物 Active CN116075516B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2010409.7 2020-07-07
GBGB2010409.7A GB202010409D0 (en) 2020-07-07 2020-07-07 Pharmaceutical compounds
PCT/GB2021/051731 WO2022008911A1 (en) 2020-07-07 2021-07-07 Benzodiazepine derivatives useful in treating a respiratory syncytial virus infection

Publications (2)

Publication Number Publication Date
CN116075516A CN116075516A (zh) 2023-05-05
CN116075516B true CN116075516B (zh) 2026-02-03

Family

ID=72050502

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180053511.8A Active CN116075516B (zh) 2020-07-07 2021-07-07 可用于治疗呼吸道合胞病毒感染的苯二氮杂䓬衍生物

Country Status (10)

Country Link
US (1) US12678446B2 (cg-RX-API-DMAC7.html)
EP (1) EP4178964A1 (cg-RX-API-DMAC7.html)
JP (1) JP7840923B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230035597A (cg-RX-API-DMAC7.html)
CN (1) CN116075516B (cg-RX-API-DMAC7.html)
BR (1) BR112023000142A2 (cg-RX-API-DMAC7.html)
CA (1) CA3188752A1 (cg-RX-API-DMAC7.html)
GB (1) GB202010409D0 (cg-RX-API-DMAC7.html)
MX (1) MX2023000440A (cg-RX-API-DMAC7.html)
WO (1) WO2022008911A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201911944D0 (en) 2019-08-20 2019-10-02 Reviral Ltd Pharmaceutical compounds
GB201915932D0 (en) 2019-11-01 2019-12-18 Reviral Ltd Pharmaceutical compounds
GB202010409D0 (en) 2020-07-07 2020-08-19 Reviral Ltd Pharmaceutical compounds
GB202102602D0 (en) 2021-02-24 2021-04-07 Reviral Ltd Pharmaceutical compounds
WO2024252355A1 (en) 2023-06-08 2024-12-12 Pfizer Inc. Pediatric dosing regimens comprising a fusion inhibitor for the treatment of rsv
WO2025120500A1 (en) 2023-12-06 2025-06-12 Pfizer Inc. Benzodiazepine compounds as n-protein inhibitors
CN122580320A (zh) 2024-01-16 2026-08-14 辉瑞大药厂 作为n-蛋白抑制剂的苯二氮䓬吡唑甲酰胺类
CN121621343B (zh) * 2026-02-02 2026-05-15 云南大学 一种化合物在防控植物病原真菌尖孢镰刀菌上的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004026843A1 (en) * 2002-09-20 2004-04-01 Arrow Therapeutics Limited Benzodiazepine derivatives and pharmaceutical compositions containing them
CN108200760A (zh) * 2015-07-22 2018-06-22 英安塔制药有限公司 作为rsv抑制剂的苯并二氮杂*衍生物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01011052A (es) * 1999-04-30 2002-11-22 Univ Michigan Aplicaciones terapeuticas de benzodiazepinas pro-apoctoticas.
ATE410161T1 (de) 2003-05-02 2008-10-15 Elan Pharm Inc 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen
GB0312365D0 (en) 2003-05-30 2003-07-02 Univ Aston Novel 3-substituted-1, 4-benzodiazepines
US20070293482A1 (en) 2004-03-19 2007-12-20 Novartis Pharmaceuticals Corporation Process for Preparing Benzodiazepines
GB0406280D0 (en) 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
GB0406282D0 (en) 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406279D0 (en) 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
US20070032475A1 (en) 2005-04-15 2007-02-08 Ye Xiaocong M Novel compounds useful for bradykinin B1 receptor antagonism
TW201113262A (en) 2009-09-03 2011-04-16 Arrow Therapeutics Ltd Chemical compounds
WO2011151651A1 (en) 2010-06-03 2011-12-08 Arrow Therapeutics Limited Benzodiazepine compounds useful for the treatment of hepatitis c
WO2011151652A1 (en) 2010-06-03 2011-12-08 Arrow Therapeutics Limited Benzodiazepine compounds useful for the treatment of hepatitis c
GB201506448D0 (en) 2015-04-16 2015-06-03 Univ Durham An antimicrobial compound
GB201613942D0 (en) 2016-08-15 2016-09-28 Univ Of Durham The An antimicrobial compound
WO2018085378A1 (en) 2016-11-01 2018-05-11 Milliken & Company Leuco polymers as bluing agents in laundry care compositions
WO2018129287A1 (en) 2017-01-06 2018-07-12 Enanta Pharmaceuticals, Inc. Heteroaryldiazepine derivatives as rsv inhibitors
WO2018152413A1 (en) 2017-02-16 2018-08-23 Enanta Pharmaceuticals, Inc. Processes for the preparation of benzodiazepine derivatives
WO2018226801A1 (en) 2017-06-07 2018-12-13 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as rsv inhibitors
KR101970214B1 (ko) * 2017-07-17 2019-08-27 이화여자대학교 산학협력단 유기금속 화합물, 이들의 자기 조립체 및 이를 포함한 종양 진단 또는 치료용 조성물
WO2019094920A1 (en) 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as rsv inhibitors
EP3781571B1 (en) * 2018-04-20 2024-01-17 F. Hoffmann-La Roche AG N-[4-oxo-2,3-dihydro-pyrido[3,2-b][1,4]oxazepin-3-yl]-5,6-dihydro-4h-pyrrolo[1,2-b]pyrazole-2-carboxamide derivatives and related compounds as rip1 kinase inhibitors for treating e.g. irritable bowel syndrome (ibs)
WO2020190935A1 (en) 2019-03-18 2020-09-24 Enanta Pharmaceuticals, Inc. Benzodiazepine derivatives as rsv inhibitors
GB201911944D0 (en) 2019-08-20 2019-10-02 Reviral Ltd Pharmaceutical compounds
GB201915273D0 (en) * 2019-10-22 2019-12-04 Reviral Ltd Pharmaceutical compounds
GB201915932D0 (en) 2019-11-01 2019-12-18 Reviral Ltd Pharmaceutical compounds
GB202010409D0 (en) 2020-07-07 2020-08-19 Reviral Ltd Pharmaceutical compounds
GB202010408D0 (en) 2020-07-07 2020-08-19 Reviral Ltd Pharmaceutical compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004026843A1 (en) * 2002-09-20 2004-04-01 Arrow Therapeutics Limited Benzodiazepine derivatives and pharmaceutical compositions containing them
CN108200760A (zh) * 2015-07-22 2018-06-22 英安塔制药有限公司 作为rsv抑制剂的苯并二氮杂*衍生物

Also Published As

Publication number Publication date
MX2023000440A (es) 2023-04-13
KR20230035597A (ko) 2023-03-14
BR112023000142A2 (pt) 2023-01-31
GB202010409D0 (en) 2020-08-19
US12678446B2 (en) 2026-07-14
EP4178964A1 (en) 2023-05-17
WO2022008911A1 (en) 2022-01-13
CA3188752A1 (en) 2022-01-13
US20230270751A1 (en) 2023-08-31
CN116075516A (zh) 2023-05-05
JP7840923B2 (ja) 2026-04-06
JP2023539985A (ja) 2023-09-21

Similar Documents

Publication Publication Date Title
CN116075516A (zh) 可用于治疗呼吸道合胞病毒感染的苯二氮杂䓬 衍生物
JP7471348B2 (ja) ブルトン型チロシンキナーゼの阻害剤及びその使用方法
EP3573987B1 (en) Tyrosine amide derivatives as rho- kinase inhibitors
US20240150377A1 (en) Modulators of cystic fibrosis transmembrane conductance regulator
US20240018161A1 (en) Modulators of cystic fibrosis transmembrane conductance regulator
CN114555604B (zh) 药物化合物
WO2022076626A1 (en) Modulators of cystic fibrosis transmembrane conductance regulator
EP4129996A1 (en) Novel aminopyrimidine egfr inhibitor
WO2013014567A1 (en) Indazoles
US11332465B2 (en) Diarylthiohydantoin compound as androgen receptor antagonist
CN116075515A (zh) 可用于治疗呼吸道合胞病毒感染的苯二氮杂䓬衍生物
CN114761397B (zh) 用于治疗呼吸道合胞病毒(rsv)感染的苯并二氮䓬衍生物
KR20150110569A (ko) 호흡기 합포체 바이러스의 항바이러스제로서의 퀴녹살리논 및 디하이드로퀴녹살리논
WO2018103058A1 (en) Inhibitors of bruton's tyrosine kinase and methods of their use
HK40094055B (en) Benzodiazepine derivatives useful in treating a respiratory syncytial virus infection
HK40094055A (en) Benzodiazepine derivatives useful in treating a respiratory syncytial virus infection
OA16848A (en) Indazoles

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40094055

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant